These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 10872646
1. Population pharmacokinetics of long-term oral amiodarone therapy. Pollak PT, Bouillon T, Shafer SL. Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646 [Abstract] [Full Text] [Related]
2. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration. Kotake T, Takada M, Goto T, Komamura K, Kamakura S, Morishita H. J Clin Pharm Ther; 2006 Jun; 31(3):237-43. PubMed ID: 16789989 [Abstract] [Full Text] [Related]
3. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients. Araki R, Yukawa E, Nakashima MN, Fukuchi H, Sasaki H, Yano K, Nakashima M. Ther Drug Monit; 2011 Dec; 33(6):750-6. PubMed ID: 22105593 [Abstract] [Full Text] [Related]
4. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses. De Clercq D, Baert K, Croubels S, van Loon G, Maes A, Tavernier R, Deprez P, De Backer P. Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906 [Abstract] [Full Text] [Related]
5. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. Brien JF, Jimmo S, Brennan FJ, Armstrong PW, Abdollah H. Drug Metab Dispos; 1990 Mar; 18(6):846-51. PubMed ID: 1981527 [Abstract] [Full Text] [Related]
6. Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans. Brennan FJ, Brien JF, Armstrong PW. Can J Cardiol; 1991 Apr; 7(3):117-24. PubMed ID: 2044013 [Abstract] [Full Text] [Related]
7. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals]. Gaete LE, Ortiz M, Soto J, Saavedra I. Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224 [Abstract] [Full Text] [Related]
8. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis. Terziivanov D, Atanasova I, Dimitrova V, Robeva R, Unger S, Mück W. Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone. Shayeganpour A, Hamdy DA, Brocks DR. Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and body distribution of amiodarone in man. Plomp TA, van Rossum JM, Robles de Medina EO, van Lier T, Maes RA. Arzneimittelforschung; 1984 Apr; 34(4):513-20. PubMed ID: 6540111 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration. Plomp TA, Wiersinga WM, Van Rossum JM, Maes RA. In Vivo; 1987 Apr; 1(5):265-79. PubMed ID: 2979794 [Abstract] [Full Text] [Related]
12. A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor. Teng R, Sarich TC, Eriksson UG, Hamer JE, Gillette S, Schützer KM, Carlson GF, Kowey PR. J Clin Pharmacol; 2004 Sep; 44(9):1063-71. PubMed ID: 15317834 [Abstract] [Full Text] [Related]
13. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Kashima A, Funahashi M, Fukumoto K, Komamura K, Kamakura S, Kitakaze M, Ueno K. Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949 [Abstract] [Full Text] [Related]
14. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K. Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients. Aso R, Ohashi K, Katoh T, Ogata H. Int J Clin Pharmacol Res; 2001 Jun; 21(3-4):137-46. PubMed ID: 12067143 [Abstract] [Full Text] [Related]
17. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%. Knibbe CA, Zuideveld KP, DeJongh J, Kuks PF, Aarts LP, Danhof M. Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748 [Abstract] [Full Text] [Related]
18. Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy. Tisdale JE, Wroblewski HA, Hammoud ZT, Rieger KM, Young JV, Wall DS, Kesler KA. Clin Ther; 2007 Oct; 29(10):2226-34. PubMed ID: 18042479 [Abstract] [Full Text] [Related]
19. Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding. Campos Moreno E, Merino Sanjuán M, Merino V, Nácher A, Martín Algarra RV, Casabó VG. Eur J Pharm Sci; 2007 Feb; 30(2):190-7. PubMed ID: 17218087 [Abstract] [Full Text] [Related]
20. Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis. Fukuchi H, Nakashima M, Araki R, Komiya N, Hayano M, Yano K, Sasaki H, Yukawa E. J Clin Pharm Ther; 2009 Jun; 34(3):329-36. PubMed ID: 19646079 [Abstract] [Full Text] [Related] Page: [Next] [New Search]